Latest

There is a tremendous, untapped market of undiagnosed patients for a variety of conditions, writes John Pagliuca. But how do you identify them when they are essentially hidden from view through conventional means?

Clinical trial data from completed trials are beginning to be shared through a variety of channels. While skeptics remain, there is evidence that this data can lead to practice-changing behavior in patient care.

Emerging Pharma Leaders

Compliance Top of Mind

There is never a lack of legal or regulatory issues to keep track of—and worry about—in the life sciences industry. The articles from Pharmaceutical Executive provide a look at the latest in compliance for marketing, labeling, and export control, as well as offer tips to stay compliant in the coming years.